-
Posted by
Two Blokes Mon at 6:30 PM -
Filed in
Stock
-
2 views
UroGen Pharma Ltd. (NASDAQ:URGN ) Q1 2025 Earnings Conference Call May 12, 2025 10:00 AM ET Company Participants Vincent Perrone - Senior Director, Investor Relations Liz Barrett - President and Chief Executive Officer Mark Schoenberg - Chief Medical Officer David Lin - Chief Commercial Officer Chris Degnan - Chief Financial Officer Conference Call Participants Tara Bancroft - TD Cowen Kelsey Goodwin - Guggenheim Leland Gershell - Oppenheimer Raghuram Selvaraju - H.
